Health Condition 1: K053- Chronic periodontitis
Conditions
Interventions
Intervention1: systemic administration of resveratrol: 150mg 1 tablet daily for 30 days
Control Intervention1: Resveratrol capsule systemic administration and placebo: Resveratrol is a polyphenol stil
Sponsors
katamneni poojitha
Eligibility
Inclusion criteria
Inclusion criteria: Patients with moderately controlled diabetes mellitus (HbA1c 6-7) patients with generalized pocket depth of 5- 6 mm and CAL � 5mm. Patients having atleast 20 permanent teeth. Should not have undergone any form of dental treatment
Exclusion criteria
Exclusion criteria: 1. Patients with any systemic disease other than diabetes. 2. Habit of smoking 3. Pregnancy or lactation 4. Used antibiotics /or anti- inflammatory drugs in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Periodontal therapy proved to be effective in reducing the inflammatory state and oxidative stress, as well as improving the glycemic control in diabetic patients. The present study is planned to observe the benefits of systemic administration of resveratrol in chronic periodontitis patients with type II diabetes before and after scaling and rootplaning. Parameters were recorded at baseline, 7 weeks postoperative. Primary outcome parameters assessed were HbA1C, Probing pocket depth (PPD) and Clinical attachment level (CAL).Timepoint: Baseline 7 weeks post operative | — |
Secondary
| Measure | Time frame |
|---|---|
| plaque index(PI), Modified sulcular bleeding index(MSBI) as secondary outcome parameters.Timepoint: Baseline 7 weeks post operative | — |
Countries
India
Contacts
Public Contactkatamneni poojitha
sibar institute of dental sciences
Outcome results
None listed